Does Nicobrevin help people to stop smoking

Nicobrevin is a proprietary product containing quinine, menthyl valerate, camphor and eucalyptus oil marketed as an aid to smoking cessation. No randomised trials with long-term follow-up of smoking status were identified, so there was no evidence to assess efficacy.

Authors' conclusions: 

There is no evidence available from long-term trials that Nicobrevin can aid smoking cessation.

Read the full abstract...
Background: 

Nicobrevin is a proprietary product marketed as an aid to smoking cessation. It contains quinine, menthyl valerate, camphor and eucalyptus oil.

Objectives: 

The objective of this review was to assess the effects of Nicobrevin on long-term smoking cessation

Search strategy: 

We searched the Cochrane Tobacco Addiction Group trials register. Most recent search was January 2009.

Selection criteria: 

Randomized trials comparing Nicobrevin to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow up.

Data collection and analysis: 

Data were sought on the outcome, method of randomisation, and completeness of follow up.

Main results: 

We identified no trials meeting the full inclusion criteria including long-term follow-up.

Share/Save